Plus Therapeutics Inc (PSTV) — Cash Flow-to-Debt Ratio
Plus Therapeutics Inc (PSTV) has a Cash Flow-to-Debt Ratio of -0.78x as of March 2026, meaning its operating cash flow of $-6.24 Million could theoretically repay -1% of its total liabilities ($7.96 Million) in one year. Check PSTV capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Plus Therapeutics Inc Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Plus Therapeutics Inc across 28 annual periods. Also explore how large is Plus Therapeutics Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Plus Therapeutics Inc (1998–2025)
Year-by-year debt coverage analysis for Plus Therapeutics Inc. For market capitalisation and broader financial context, see PSTV market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.69x | $-20.77 Million | $12.33 Million | ▼ -148.8% |
| 2024 | -0.68x | $-10.55 Million | $15.58 Million | ▲ +32.9% |
| 2023 | -1.01x | $-12.85 Million | $12.74 Million | ▼ -35.5% |
| 2022 | -0.74x | $-12.97 Million | $17.42 Million | ▲ +19.3% |
| 2021 | -0.92x | $-10.28 Million | $11.14 Million | ▲ +0.8% |
| 2020 | -0.93x | $-8.43 Million | $9.07 Million | ▼ -247.3% |
| 2019 | -0.27x | $-5.91 Million | $22.07 Million | ▲ +58.1% |
| 2018 | -0.64x | $-11.97 Million | $18.77 Million | ▲ +34.5% |
| 2017 | -0.97x | $-18.13 Million | $18.61 Million | ▼ -17.8% |
| 2016 | -0.83x | $-19.53 Million | $23.62 Million | ▼ -3.0% |
| 2015 | -0.80x | $-20.47 Million | $25.49 Million | ▼ -17.6% |
| 2014 | -0.68x | $-30.33 Million | $44.42 Million | ▲ +23.1% |
| 2013 | -0.89x | $-34.56 Million | $38.93 Million | ▼ -1.5% |
| 2012 | -0.87x | $-32.19 Million | $36.80 Million | ▼ -3.0% |
| 2011 | -0.85x | $-35.32 Million | $41.59 Million | ▼ -56.6% |
| 2010 | -0.54x | $-23.57 Million | $43.47 Million | ▲ +35.3% |
| 2009 | -0.84x | $-23.81 Million | $28.41 Million | ▲ +16.4% |
| 2008 | -1.00x | $-33.39 Million | $33.33 Million | ▼ -3.2% |
| 2007 | -0.97x | $-30.00 Million | $30.91 Million | ▼ -110.1% |
| 2006 | -0.46x | $-16.48 Million | $35.68 Million | ▼ -1343.1% |
| 2005 | -0.03x | $-1.10 Million | $34.40 Million | ▲ +96.8% |
| 2004 | -1.00x | $-12.57 Million | $12.64 Million | ▼ -81.0% |
| 2003 | -0.55x | $-7.25 Million | $13.18 Million | ▼ -6.4% |
| 2002 | -0.52x | $-6.89 Million | $13.32 Million | ▲ +71.1% |
| 2001 | -1.79x | $-8.32 Million | $4.66 Million | ▼ -75.8% |
| 2000 | -1.02x | $-2.98 Million | $2.93 Million | ▼ -133.3% |
| 1999 | -0.44x | $-5.11 Million | $11.72 Million | ▲ +73.9% |
| 1998 | -1.67x | $-1.52 Million | $912.00K | — |